MeSH Browser

MeSH Heading: Lewis X Antigen
Tree Number(s): D23.050.285.050.050; D23.050.301.264.900.050; D23.050.301.264.965.500; D23.050.301.290.544.059; D23.050.550.325.050; D23.050.705.230.544.059; D23.101.100.900.050; D23.101.140.075.050
Unique ID: D016256
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D016256
Scope Note: A trisaccharide antigen expressed on glycolipids and many cell-surface glycoproteins. In the blood the antigen is found on the surface of NEUTROPHILS; EOSINOPHILS; and MONOCYTES. In addition, Lewis X antigen is a stage-specific embryonic antigen.
Entry Term(s): 3 alpha-Fucosyl-N-Acetyl Lactosamine; Antigens, CD15; CD15 Antigen; CD15 Antigens; Galbeta(1-4)Fucalpha(1-3)GlcNAc; Hapten X; Le(X) Antigen; Leu-M1 Antigens; Lewis X Hapten; Lewis X Related Antigens; SSEA 1; SSEA-1; SSEA-1 Determinant; Stage-Specific Embryonic Antigen-1
Registry Number: 0
Previous Indexing: Antigenic Determinants (1970-1990); Antigens, Neoplasm (1973-1990); Glycolipids (1966-1990); Tumor Markers, Biological (1988-1990)
Public MeSH Note: 2018; see ANTIGENS, CD15 1995-2017 and STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; for LEU-M1 ANTIGENS see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; LEWIS X ANTIGEN was indexed under ANTIGENS, CD and ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1992-94; and under ANTIGENS, DIFFERENTIATION 1987-91; LEWIS X HAPTEN was indexed under GANGLIOSIDES 1987-94
History Note: 2018 (1990); for LEU-M1 ANTIGENS use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; for CD15 ANTIGENS use CD15 ANTIGEN 1987-94; use LEWIS X HAPTEN 1987-94
Date Established: 1991/01/01
Date of Entry: 1990/06/08
Revision Date: 2019/07/09

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analogs & derivatives (AA)

analysis (AN)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemistry (CH)

classification (CL)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacology (PD)

physiology (PH)

poisoning (PO)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

Biological Factors [D23]
- Antigens [D23.050]
  - Antigens, Neoplasm [D23.050.285]
    - Antigens, Tumor-Associated, Carbohydrate [D23.050.285.050]

Biological Factors [D23]
- Antigens [D23.050]
  - Antigens, Surface [D23.050.301]
    - Antigens, Differentiation [D23.050.301.264]
      - Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
        
        Lipopolysaccharide Receptors [D23.050.301.264.900.045]
        
        Lewis X Antigen [D23.050.301.264.900.050]
        
        Sialyl Lewis X Antigen [D23.050.301.264.900.050.500]
        
        Platelet Endothelial Cell Adhesion Molecule-1 [D23.050.301.264.900.131]
        
        Sialic Acid Binding Ig-like Lectin 3 [D23.050.301.264.900.565]

Biological Factors [D23]
- Antigens [D23.050]
  - Antigens, Surface [D23.050.301]
    - Antigens, Differentiation [D23.050.301.264]
      - Stage-Specific Embryonic Antigens [D23.050.301.264.965]
        
        Lewis X Antigen [D23.050.301.264.965.500]
        
        Sialyl Lewis X Antigen [D23.050.301.264.965.500.500]

Biological Factors [D23]
- Antigens [D23.050]
  - Antigens, Surface [D23.050.301]
    - Blood Group Antigens [D23.050.301.290]
      - Lewis Blood Group Antigens [D23.050.301.290.544]
        
        Lewis X Antigen [D23.050.301.290.544.059]
        
        Sialyl Lewis X Antigen [D23.050.301.290.544.059.500]
        
        CA-19-9 Antigen [D23.050.301.290.544.119]

Biological Factors [D23]
- Antigens [D23.050]
  - Epitopes [D23.050.550]
    - Antigens, Tumor-Associated, Carbohydrate [D23.050.550.325]

Biological Factors [D23]
- Antigens [D23.050]
  - Isoantigens [D23.050.705]
    - Blood Group Antigens [D23.050.705.230]
      - Lewis Blood Group Antigens [D23.050.705.230.544]
        
        Lewis X Antigen [D23.050.705.230.544.059]
        
        Sialyl Lewis X Antigen [D23.050.705.230.544.059.500]
        
        CA-19-9 Antigen [D23.050.705.230.544.119]

Biological Factors [D23]
- Biomarkers [D23.101]
  - Antigens, Differentiation [D23.101.100]
    - Antigens, Differentiation, Myelomonocytic [D23.101.100.900]

Biological Factors [D23]
- Biomarkers [D23.101]
  - Biomarkers, Tumor [D23.101.140]
    - Antigens, Tumor-Associated, Carbohydrate [D23.101.140.075]

Lewis X Antigen Preferred

Concept UI: M0024834
Registry Number: 0
Scope Note: A trisaccharide antigen expressed on glycolipids and many cell-surface glycoproteins. In the blood the antigen is found on the surface of NEUTROPHILS; EOSINOPHILS; and MONOCYTES. In addition, Lewis X antigen is a stage-specific embryonic antigen.
Terms: Lewis X Antigen Preferred Term
Term UI T048418
Date03/26/1990
LexicalTag EPO
ThesaurusID NLM (1991); CD15 Antigen
Term UI T048412
Date04/15/1994
LexicalTag NON
ThesaurusID NLM (1995); CD15 Antigens
Term UI T048413
Date04/15/1994
LexicalTag NON
ThesaurusID NLM (1995); Antigens, CD15
Term UI T048414
Date01/01/1999
LexicalTag ACX
ThesaurusID NLM (1991); Lewis X Hapten
Term UI T048415
Date04/28/1994
LexicalTag EPO
ThesaurusID NLM (1995); 3 alpha-Fucosyl-N-Acetyl Lactosamine
Term UI T717944
Date04/11/2008
LexicalTag NON
ThesaurusID NLM (2009); SSEA 1
Term UI T048419
Date05/31/1994
LexicalTag ABB
ThesaurusID NLM (1995); SSEA-1
Term UI T048420
Date03/26/1990
LexicalTag ABB
ThesaurusID NLM (1991); SSEA-1 Determinant
Term UI T048422
Date03/26/1990
LexicalTag NON
ThesaurusID NLM (1991); Stage-Specific Embryonic Antigen-1
Term UI T048423
Date04/15/1994
LexicalTag NON
ThesaurusID NLM (1995); Le(X) Antigen
Term UI T048424
Date03/26/1990
LexicalTag NON
ThesaurusID NLM (1991); Galbeta(1-4)Fucalpha(1-3)GlcNAc
Term UI T717911
Date04/11/2008
LexicalTag NON
ThesaurusID NLM (2009); Leu-M1 Antigens
Term UI T048411
Date04/15/1994
LexicalTag NON
ThesaurusID NLM (1995); Hapten X
Term UI T048416
Date03/26/1990
LexicalTag NON
ThesaurusID NLM (1991)

Lewis X Related Antigens Related

Lewis X Antigen MeSH Descriptor Data 2023